Physiology of IgD. V. Enhancement of antibody responses in vivo by allo anti-IgD is due primarily to an indirect effect on B cells.
Although responses of BALB/c mice to TNP-Ficoll or TNP-Brucella abortus are usually decreased by injection of allo anti-IgD (anti-Igh-5a) given 1 day before antigen, increased responses are obtained if a lymphokine mixture (SN) containing IL 2 is also injected. Simultaneous injection of anti-IgD and SN 4 days after priming with TNP-KLH induces an increase in antibody production similar to that induced by a second antigen injection. Injected together with a second injection of TNP-KLH at that time, anti-IgD and SN cause a synergistic enhancement of the secondary response. In allotype heterozygous (BALB/c X SJL)F1 mice injected with anti-IgD directed against one allotype, this enhancement of the secondary response is seen predominantly in the alternate allotype, because the IgG response of linked allotype specificity is slightly suppressed by the anti-IgD alone and is less enhanced than the alternate allotype by anti-IgD plus SN. Cells from unprimed heterozygous mice, incubated with anti-Igh-5a in vitro and transferred, together with antigen, to TNP-KLH-primed recipients, cause a much greater enhancement of the IgG responses of the Igb than of the Iga allotype in recipients. If, however, SN is also injected into the recipients, the anti-TNP response of both IgG allotypes is greatly enhanced.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage* / Q000502:physiology; D000917:Antibody Formation; D000955:Antigens, T-Independent / Q000008:administration & dosage; D001402:B-Lymphocytes / Q000276:immunology*; D006433:Hemocyanins / Q000008:administration & dosage; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D007117:Immunization, Secondary; D007072:Immunoglobulin D / Q000008:administration & dosage / Q000276:immunology* / Q000502:physiology*; D007518:Isoantibodies / Q000008:administration & dosage* / Q000502:physiology; D008222:Lymphokines / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D013154:Spleen / Q000166:cytology
D000888:Antibodies, Anti-Idiotypic; D000955:Antigens, T-Independent; D007072:Immunoglobulin D; D007518:Isoantibodies; D008222:Lymphokines; C039951:anti-IgD; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin